Shohei Maekawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shohei Maekawa has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Haruko Kumanogoh
Division of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Japan
7 shared publicationsShun Nakamura
Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, Koganei, Japan
6 shared publicationsFumio Hayashi
Graduate School of Science, Kobe University, Rokkodaicho 1-1, Nada, Kobe 657-8501, Japan
5 shared publications- Mitsuhiro Morita
Department of Biology, Graduate School of Science, Kobe University, Kobe, Hyogo, 657-8501, Japan
5 shared publications Katsutoshi Taguchi
4 shared publicationsYuumi Kobayashi
Divison of Biology, Graduate School of Science, Kobe-University, Kobe 657-8501, Japan
3 shared publications
Latest Publications
- 28 October 2025
- Published by Elsevier in Biophysical Journal
- Vol. 124 (23) , 4368-4378
Membrane binding and clustering of NAP-22, a neuron-enriched intrinsically disordered protein
- 28 October 2025
- Published by Elsevier in Biophysical Journal
- Vol. 124 (23) , 4368-4378
Membrane binding and clustering of NAP-22, a neuron-enriched intrinsically disordered protein
- 4 January 2024
- Published by Elsevier in Neuroscience Letters
- Vol. 821, 137623
Oligomerization and aggregation of NAP-22 with several metal ions
- 4 January 2024
- Published by Elsevier in Neuroscience Letters
- Vol. 821, 137623
Oligomerization and aggregation of NAP-22 with several metal ions
- 1 September 2020
- Published by Elsevier in Neuroscience Letters
- Vol. 736, 135288
The effects of phospholipids and fatty acids on the oligomer formation of NAP-22
- 1 September 2020
- Published by Elsevier in Neuroscience Letters
- Vol. 736, 135288
The effects of phospholipids and fatty acids on the oligomer formation of NAP-22
- 1 May 2018
- Published by Elsevier in Neuroscience Letters
- Vol. 675, 59-63
Interaction of dynamin I with NAP-22, a neuronal protein enriched in the presynaptic region
- 1 May 2018
- Published by Elsevier in Neuroscience Letters
- Vol. 675, 59-63
Interaction of dynamin I with NAP-22, a neuronal protein enriched in the presynaptic region
- 1 April 2018
- Published by Elsevier in Neuroscience Letters
- Vol. 673, 132-135
Inhibitory effect of several sphingolipid metabolites on calcineurin
- 1 April 2018
- Published by Elsevier in Neuroscience Letters
- Vol. 673, 132-135
Inhibitory effect of several sphingolipid metabolites on calcineurin
- 1 July 2015
- Published by Elsevier in Neuroscience Letters
- Vol. 600, 244-248
Tight binding of NAP-22 with acidic membrane lipids
- 1 July 2015
- Published by Elsevier in Neuroscience Letters
- Vol. 600, 244-248
Tight binding of NAP-22 with acidic membrane lipids
- 18 May 2015
- Published by Wiley in Journal of Neuroscience Research
- Vol. 93 (9) , 1462-1470
Ganglioside contained in the neuronal tissue‐enriched acidic protein of 22 kDa (NAP‐22) fraction prepared from the detergent‐resistant membrane microdomain of rat brain inhibits the phosphatase activity of calcineurin
Neurons have well‐developed membrane microdomains called “rafts” that are recovered as a detergent‐resistant membrane microdomain fraction (DRM). Neuronal tissue‐enriched acidic protein of 22 kDa (NAP‐22) is one of the major protein components of neuronal DRM. To determine the cellular function of NAP‐22, interacting proteins were screened with an immunoprecipitation assay, and calcineurin (CaN) was detected. Further studies with NAP‐22 prepared from DRM and CaN expressed in bacteria showed the binding of these proteins and a dose‐dependent inhibitory effect of the NAP‐22 fraction on the phosphatase activity of CaN. On the other hand, NAP‐22 expressed in bacteria showed low binding to CaN and a weak inhibitory effect on phosphatase activity. To solve this discrepancy, identification of a nonprotein component that modulates CaN activity in the DRM‐derived NAP‐22 fraction was attempted. After lyophilization, a lipid fraction was extracted with chloroform/methanol. The lipid fraction showed an inhibitory effect on CaN without NAP‐22, and further fractionation of the extract with thin‐layer chromatography showed the presence of several lipid bands having an inhibitory effect on CaN. The mobility of these bands coincided with that of authentic ganglioside (GM1a, GD1a, GD1b, and GT1b), and authentic ganglioside showed an inhibitory effect on CaN. Treatment of lipid with endoglycoceramidase, which degrades ganglioside to glycochain and ceramide, caused a diminution of the inhibitory effect. These results show that DRM‐derived NAP‐22 binds several lipids, including ganglioside, and that ganglioside inhibits the phosphatase activity of CaN.
- 18 May 2015
- Published by Wiley in Journal of Neuroscience Research
- Vol. 93 (9) , 1462-1470
Ganglioside contained in the neuronal tissue‐enriched acidic protein of 22 kDa (NAP‐22) fraction prepared from the detergent‐resistant membrane microdomain of rat brain inhibits the phosphatase activity of calcineurin
Neurons have well‐developed membrane microdomains called “rafts” that are recovered as a detergent‐resistant membrane microdomain fraction (DRM). Neuronal tissue‐enriched acidic protein of 22 kDa (NAP‐22) is one of the major protein components of neuronal DRM. To determine the cellular function of NAP‐22, interacting proteins were screened with an immunoprecipitation assay, and calcineurin (CaN) was detected. Further studies with NAP‐22 prepared from DRM and CaN expressed in bacteria showed the binding of these proteins and a dose‐dependent inhibitory effect of the NAP‐22 fraction on the phosphatase activity of CaN. On the other hand, NAP‐22 expressed in bacteria showed low binding to CaN and a weak inhibitory effect on phosphatase activity. To solve this discrepancy, identification of a nonprotein component that modulates CaN activity in the DRM‐derived NAP‐22 fraction was attempted. After lyophilization, a lipid fraction was extracted with chloroform/methanol. The lipid fraction showed an inhibitory effect on CaN without NAP‐22, and further fractionation of the extract with thin‐layer chromatography showed the presence of several lipid bands having an inhibitory effect on CaN. The mobility of these bands coincided with that of authentic ganglioside (GM1a, GD1a, GD1b, and GT1b), and authentic ganglioside showed an inhibitory effect on CaN. Treatment of lipid with endoglycoceramidase, which degrades ganglioside to glycochain and ceramide, caused a diminution of the inhibitory effect. These results show that DRM‐derived NAP‐22 binds several lipids, including ganglioside, and that ganglioside inhibits the phosphatase activity of CaN.
- 1 March 2013
- Published by Elsevier in Neuroscience Letters
- Vol. 537, 50-54
Interaction of NAP-22 with brain glutamic acid decarboxylase (GAD)
- 1 March 2013
- Published by Elsevier in Neuroscience Letters
- Vol. 537, 50-54
Interaction of NAP-22 with brain glutamic acid decarboxylase (GAD)
- 19 September 2011
- Published by Wiley in Journal of Neuroscience Research
- Vol. 90 (1) , 21-27
Inhibitory effect of NAP‐22 on the phosphatase activity of synaptojanin‐1
Endocytosis of the synaptic vesicle is a complicated process, in which many proteins and lipids participate. Phosphatidylinositol 4,5‐bisphosphate (PIP2) plays important roles in the process, and the dynamic regulation of this lipid is one of the key events. Synaptojanin is a PIP2 phosphatase, and dephosphorylation of PIP2 of the clathrin coated‐vesicle results in the uncoating of the vesicle. NAP‐22 is one of the major proteins of the neuronal detergent‐resistant membrane microdomain and localizes in both the presynaptic plasma membrane and the synaptic vesicle. To elucidate the role of NAP‐22 in synaptic function, a screening of the NAP‐22 binding proteins through pull‐down assay was performed. In addition to CapZ protein, synaptojanin‐1 was detected by LC‐MS/MS, and Western blotting using antisynaptojanin‐1 confirmed this result. The interaction seems to be important in the course of synaptic vesicle endocytosis, because NAP‐22 inhibited the phosphatase activity of synaptojanin in a dose‐dependent manner. The inhibitory region for 5‐phosphatase and the binding region for PIP2 overlapped in the amino acid sequence of NAP‐22, so elucidation of the regulatory mechanism of the PIP2 binding ability of NAP‐22 could be important in understanding the membrane dynamics at the presynaptic region.
- 19 September 2011
- Published by Wiley in Journal of Neuroscience Research
- Vol. 90 (1) , 21-27
Inhibitory effect of NAP‐22 on the phosphatase activity of synaptojanin‐1
Endocytosis of the synaptic vesicle is a complicated process, in which many proteins and lipids participate. Phosphatidylinositol 4,5‐bisphosphate (PIP2) plays important roles in the process, and the dynamic regulation of this lipid is one of the key events. Synaptojanin is a PIP2 phosphatase, and dephosphorylation of PIP2 of the clathrin coated‐vesicle results in the uncoating of the vesicle. NAP‐22 is one of the major proteins of the neuronal detergent‐resistant membrane microdomain and localizes in both the presynaptic plasma membrane and the synaptic vesicle. To elucidate the role of NAP‐22 in synaptic function, a screening of the NAP‐22 binding proteins through pull‐down assay was performed. In addition to CapZ protein, synaptojanin‐1 was detected by LC‐MS/MS, and Western blotting using antisynaptojanin‐1 confirmed this result. The interaction seems to be important in the course of synaptic vesicle endocytosis, because NAP‐22 inhibited the phosphatase activity of synaptojanin in a dose‐dependent manner. The inhibitory region for 5‐phosphatase and the binding region for PIP2 overlapped in the amino acid sequence of NAP‐22, so elucidation of the regulatory mechanism of the PIP2 binding ability of NAP‐22 could be important in understanding the membrane dynamics at the presynaptic region.
- 31 December 2009
- Published by Elsevier in Neuroscience Research
- Vol. 65, S98
Expression of immunoglobulin superfamily cell adhesion molecule OBCAM in glial cells
- 31 December 2009
- Published by Elsevier in Neuroscience Research
- Vol. 65, S98
Expression of immunoglobulin superfamily cell adhesion molecule OBCAM in glial cells